6Y4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vicore Pharma Holding AB

Watchlist Manager

Watchlist

Price: 0.96 EUR -0.62% Market Closed

Market Cap: €107.3m

	Vicore Pharma Holding AB F:6Y4	SE
L	Landa App LLC OTC:LBVDS	US
U	Urban One Inc F:UA1	US
	ASBISc Enterprises PLC F:J1L	CY
D	DeepSpatial Inc OTC:DSAIF	CA
	Bunker Hill Mining Corp TSX:BNKR	CA
	Bong AB F:20L	SE
1	1CM Inc F:IQ70	CA
	Abitibi Metals Corp F:FW0	CA
	Iog PLC F:IO7	UK
	Dominari Holdings Inc F:BP2A	US
	Adcore Inc F:ADQ	CA
M	Mito Securities Co Ltd F:896	JP

Profitability Summary

Vicore Pharma Holding AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-13 110%

Negative 3Y Average Operating Margin

-5 415%

Negative Net Margin

-12 570%

Negative 3Y Average Net Margin

-5 426%

Negative Free Cash Flow Margin

-11 435%

Negative 3Y Average Free Cash Flow Margin

-4 632%

Negative ROE

-57%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3 011%

Declining ROIC

-445% > -7 287%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.